23 May 2017 - President had promised to tackle U.S. drug-pricing issues.

President Donald Trump has repeatedly excoriated pharmaceutical companies for high drug costs, but the policy and spending plans in his administration’s 2018 health budget contain almost no major proposals that would impact the industry’s pricing practices.

On the campaign trail and after taking office, Trump repeatedly criticized the drug industry. He said drugmakers were “getting away with murder” and said he’d have the U.S. government make the industry bid for government business, a dramatic proposition to cut prices that sent biotechnology and drug stocks spiraling downward on more than one occasion.

The budget details are described in a lengthy document titled “Putting America’s Health First” that appears to be a copy of the fiscal 2018 Health and Human Services Department budget. It was removed from the HHS website soon after it posted.

Read Bloomberg article